Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for ...

New checkpoint benchmarks provide “must-have” information for optimizing AI trainingSAN FRANCISCO, Aug. 04, 2025 (GLOBE ...